Potent antagonists of somatostatin: Synthesis and biology

Journal of Medicinal Chemistry

Volumn 41, Issue 7, 1998, Pages 1146-1154

  Hocart, Simon J ^a   Jain, Rahul ^a,c   Murphy, William A ^a   Taylor, John E ^a,b   Morgan, Barry ^a,b   Coy, David H ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Biomeasure Inc   (United States)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CYSTEINE; GONADORELIN; PENICILLAMINE; SOMATOSTATIN ANTIBODY;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; DATA ANALYSIS; DRUG POTENCY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MASS SPECTROMETRY; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHO CELLS; CRICETINAE; PEPTIDES; PEPTIDES, CYCLIC; RATS; SOMATOSTATIN;

EID: 0032568431     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970730q     Document Type: Article

References (45)

1. Brazeau, P.; Vale, W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J.; Guillemin, R. Hypothalamic Polypeptide that Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone. Science 1973, 179, 77-79.
2. Reisine, T.; Bell, G. I. Molecular Properties of Somatostatin Receptors. Neuroscience 1995, 67, 777-790.
3. Reisine, T.; Bell, G. I. Molecular Biology of Somatostatin Receptors. Endocrine Rev. 1995, 16, 427-442.
4. Coy, D. H.; Taylor, J. E. Receptor-Specific Somatostatin Analogues: Correlations with Biological Activity. Metabolism 1996, 34 (Suppl. 1), 21-23.
5. Raynor, K.; Murphy, W. A.; Coy, D. H.; Taylor, J. E.; Moreau, J.-P.; Yasuda, K.; Bell, G. I.; Reisine, T. Cloned Somatostatin Receptors: Identification of Subtype-Selective Peptides and Demonstration of High Affinity Binding of Linear Peptides. Mol. Pharmacol. 1993, 43, 838-844.
6. Rossowski, W. J.; Coy, D. H. Specific Inhibition of Rat Pancreatic Insulin and Glucagon Release by Receptor-Selective Somatostatin Analogues. Biochem. Biophys. Res. Commun. 1994, 205, 341-346.
7. Rossowski, W. J.; Gu, Z. F.; Akarca, U. S.; Jensen, R. T.; Coy, D. H. Characterization of Somatostatin Receptor Subtypes Controlling Rat Gastric Acid and Pancreatic Amylase Release. Peptides 1994, 15, 1421-1424.
8. Murthy, K. S.; Coy, D. H.; Makhlouf, G. M. Somatostatin Receptor-Mediated Signaling in Smooth Muscle - Activation of Phospholipase C-β3 by Gβgamma and Inhibition of Adenyl Cyclase by GαilGαo. J. Biol. Chem. 1996, 271, 23458-23463.
9. Fries, J. L.; Murphy, W. A.; Sueiras-Diaz, J.; Coy, D. H. Somatostatin Antagonist Analogue Increases GH, Insulin and Glucagon Release in the Rat. Peptides 1982, 3, 811-814.
10. Spencer, G. S. G.; Hallett, K. G. Somatostatin Antagonist Analogue Stimulates Growth in Rats. Life Sci. 1985, 37, 27-30.
11. Bass, R. T.; Buckwalter, B. L.; Patel, B. P.; Pausch, M. H.; Price, L. A.; Strnad, J.; Hadcock, J. R. Identification and Characterization of Novel Somatostatin Antagonists. Mol. Pharmacol. 1996, 50, 709-715.
12. Bass, R. T.; Buckwalter, B. L.; Patel, B. P.; Pausch, M. H.; Price, L. A.; Strnad, J.; Hadcock, J. R. Identification and Characterization of Novel Somatostatin Antagonists, Erratum. Mol. Pharmacol. 1997, 57, 170.
13. Veber, D. F.; Holly, F. W.; Nutt, R. F.; Bergstrand, S. J.; Brady, S. F.; Hirschmann, R. Highly Active Cyclic and Bicyclic Somatostatin Analogues of Reduced Ring Size. Nature 1979, 280, 512-514.
14. Nutt, R. F.; Veber, D. F.; Curley, P. E.; Saperstein, R.; Hirschmann, R. F. Somatostatin Analogues Which Define the Role of the Lysine-9 Amino Group. Int. J. Pep. Protein Res. 1983, 21, 66-73.
15. Nutt, R. F.; Saperstein, R.; Veber, D. F. Structural and Conformational Studies Regarding Tryptophan in a Cyclic Hexapeptide Somatostatin Analogue. In Peptides: Chemistry and Biology, Proceedings of the Eighth American Peptide Symposium; Hruby, V. J., Rich, D. H., Eds.; Pierce Chemical Co.: Rockford, IL, 1983; pp 345-348.
16. Veber, D. F. Design and Discovery in the Development of Peptide Analogues. In Peptides: Chemistry and Biology, Proceedings of the Twelfth American Peptide Symposium; Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; pp 3-14.
17. Ösapay, G.; Prokai, L.; Ho-Seung, K.; Medzihradszky, K. F.; Coy, D. H.; Liapakis, G.; Reisine, T.; Melacini, G.; Zhu, Q.; Wang, S. H.-H.; Mattern, R.-H.; Goodman, M. Lanthionine-Somatostatin Analogues: Synthesis, Characterizatin, Biological Activity, and Enzymatic Stability Studies. J. Med. Chem. 1997, 40, 2241-2251.
18. Freidinger, R. M.; Schwenk Perlow, D.; Randall, W. C.; Saperstein, R.; Arison, B. H.; Veber, D. F. Conformational Modifications of Cyclic Hexapeptide Somatostatin Analogues. Int. J. Pept. Protein Res. 1984, 23, 142-150.
19. Chen, L.; Skinner, S. R.; Gordon, T. D.; Taylor, J. E.; Barany, G.; Morgan, B. A. Isolation, Characterization and Synthesis of a Trisulfide Related to the Somatostatin Analogue Lanreotide. Proceedings of the Fifteenth American Peptide Symposium; 1997; in press.
20. Thurieau, C.; Janiak, P.; Krantic, S.; Guyard, C.; Pillon, A.; Kucharczyk, N.; Vilaine, J. P.; Fauchere, J. L. A New Somostatin Analogue with Optimized Ring Size Inhibits Neointimal Formation Induced by Balloon Injury in Rats Without Altering Growth Hormone Release. Eur. J. Med. Chem. 1995, 30, 115-122.
21. Van Binst, G.; Tourwé, D. Backbone Modifications in Somatostatin Analogues: Relation between Conformation and Activity. Pept. Res. 1992, 5, 8-13.
22. All analogues were assayed for antagonist activity in the presence of SRIF-14 at analogue doses up to 10 μM. Some were tested to doses of 100 μM as denoted in Table 3.
23. Bauer, W.; Briner, U.; Doepfner, W.; Haller, R.; Huguenin, R.; Marbach, P.; Petcher, T. J.; Pless, J. SMS 201-995: A Very Potent and Selective Octapeptide Analogue of Somatostatin with Prolonged Action. Life Sci. 1982, 31, 1133-1140.
24. Brady, S. F.; Nutt, R. F.; Holly, F. W.; Paleveda, W. J.; Strachan, R. G.; Bergstrand, S. J.; Veber, D. F.; Saperstein, R. Synthesis and Biological Activity of Somatostatin Analogues of Reduced Ring Size. In Peptides: Synthesis, Structure, Function. Proceedings of the Seventh American Peptide Symposium; Rich, D. H., Gross, E., Eds.; Pierce Chemical Co.: New York, 1981; pp 653-656.
25. Veber, D. F. Design and Discovery in the Development of Peptide Analogues. In Peptides: Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium; Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; pp 3-14.
26. Patel, Y. C.; Srikant, C. B. Subtype Selectivity of Peptide Analogues for all five Cloned Human Somatostatin Receptors. Endocrinology 1994, 135, 2814-2817.
27. Folkers, K.; Bowers, C. Y.; Kubiak, T.; Stepinski, J. Antagonists of the Luteinizing Hormone Releasing Hormone with Pyridyl-Alanines which Completely Inhibit Ovulation at Nanogram Dosage. Biochem. Biophys. Res. Commun. 1983, 3, 1089-1095.
28. Orbuch, M.; Taylor, J. E.; Coy, D. H.; Mrozinski, J. E.; Mantey, S.; Battey, J. F.; Moreau, J.-P.; Jensen, J. T. Discovery of a Novel Class of Neuromedin B Receptor Antagonists, Substituted Somatostatin Analogues. Mol. Pharmacol. 1993, 44, 841-850.
29. Coy, D. H.; Murphy, W. A.; Rossowski, W. J.; Hocart, S. J.; Jain, R.; Fuselier, J.; Taylor, J. E. Somatostatin Receptor Antagonists Based on a Mixed Neuromedin B Antagonist/Somatostatin Agonist. Proceedings of the Fifteenth American Peptide Symposium; 1997; in press.
30. Hocart, S. J.; Reddy, V.; Murphy, W. A.; Coy, D. H. Three-Dimensional Quantitative Structure Activity Relationships (3-D QSAR) of Somatostatin Analogues. I. Comparative Molecular Field Analysis (CoMFA) of Growth Hormone Release-Inhibiting Potencies. J. Med. Chem. 1995, 38, 1974-1989.
31. He, Y.-A.; Huang, Z.; Raynor, K.; Reisine, T.; Goodman, M. Syntheses and Conformations of Somatostatin-Related Cyclic Hexapeptides Incorporating Specific α- and β-Methylated Residues. J. Am. Chem. Soc. 1993, 115, 8066-8072.
32. Henderson, R.; Baldwin, J. M.; Ceska, T. A.; Zemlin, F.; Beckmann, E.; Downing, K. H. Model for the Structure of Bacteriorhodopsin Based on High-resolution Electron Cryomicroscopy. J. Mol. Biol. 1990, 213, 899-929.
33. Kaupmann, K.; Bruns, C.; Raulf, F.; Weber, H. P.; Mattes, H.; Lübbert, H. Two Amino Acids Located in Transmembrane Domains VI and VII, Determine the Selectivity of the Peptide Agonist SMS 201-995 for the SSTR2 Somatostatin Receptor. EMBO J. 1995, 14, 727-735.
34. IUPAC-IUB Commission of Biochemical Nomenclature (CBN) Symbols for Amino-Acid Derivatives and Peptides, Recommendations 1971. Eur. J. Biochem. 1972, 27, 201-207.
35. Murphy, W. A.; Taylor, J.; Moreau, J.-P.; Coy, D. H. Novel Heptapeptide Somatostatin Analogue Displays Antitumor Activity Independent of Effects on Growth Hormone Secretion. Pept. Res. 1989, 2, 128-132.
36. Yamada, Y.; Post, S. R.; Wang, K.; Tager, H. S.; Bell, G. I.; Seino, S. Cloning and Functional Characterization of a Family of Human and Mouse Somatostatin Receptors Expressed in Brain, Gastrointestinal Tract and Kidney. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 251-255.
37. Yasuda, K.; Rens-Domiano, S.; Breder, C. D.; Law, S. F.; Sapel, C. B.; Reisine, T.; Bell, G. I. Cloning of a Novel Somatostatin Receptor, SSTR-3, Coupled to Adenyl Cyclase. J. Biol. Chem. 1992, 267, 20422-20428.
38. Yamada, Y.; Reisine, T.; Law, S. F.; Ihara, Y.; Kubota, A.; Kagimoto, S.; Seino, M.; Seino, Y.; Bell, G. I.; Seino, S. Somatostatin Receptors, an Expanding Gene Family: Cloning and Functional Characterization of Human SSTR3, a Protein Coupled to Adenylate Cyclase. Mol. Pharmacol. 1992, 42, 2136-2142.
39. Rohrer, L.; Raulf, F.; Bruns, C.; Buettner, R.; Hofstaedter, F.; Schule, R. Cloning and Characterization of a Fourth Human Somatostatin Receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 4196-4200.
40. O'Carroll, A. M.; Raynor, K.; Lolait, S. J.; Reisine, T. Characterization of Cloned Human Somatostatin Receptor SSTR5. Mol. Pharmacol. 1994, 46, 291-298.
41. SYBYL molecular modeling software, version 6.32; Tripos Associates Inc., 1699 Hanley Rd, St. Louis, MO 63144-2913.
42. Clark, M.; Cramer, R. D., III; Van Opdenbosh, N. Validation of the General Purpose Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
43. Berthod, H.; Pullman, A. Calculation of the σ Structure of Conjugated Molecules. J. Chem. Phys. 1965, 62, 942-946.
44. Berthod, H.; Prettre, C. G.; Pullman, A. Role of σ and π Electrons on the Properties of Halogens-Substituted Conjugated Molecules. Application to the Study of Uracil and Fluorouracil. Theor. Chim. Acta 1967, 8, 212-222.
45. McCammon, J. A.; Wolynes, P. G.; Karplus, M. Picosecond Dynamics of Tyrosine Side Chains in Proteins. Biochemistry 1979, 18, 927-942.